AlphaGenome is a deep learning model from Google DeepMind that predicts how genetic variants affect gene regulation. Given a genomic position and a variant (reference → alternate allele), AlphaGenome computes expression changes across 667 cell types and tissues at single base-pair resolution.
The model processes up to 1 million base pairs of DNA sequence and outputs predictions for gene expression (RNA-seq), splicing patterns, chromatin accessibility, and other regulatory features. Unlike models that focus on protein-coding regions (about 2% of the genome), AlphaGenome specializes in the non-coding 98% where most disease-associated variants reside.
AlphaGenome builds on DeepMind's earlier Enformer model and complements AlphaMissense, which predicts effects of variants within protein-coding regions.
ProteinIQ provides a browser interface to AlphaGenome, handling the API communication and result formatting without requiring local Python setup.
AlphaGenome on ProteinIQ uses a Bring Your Own Key model. This means the tool requires a personal API key from Google DeepMind rather than using ProteinIQ's infrastructure.
AlphaGenome is licensed by DeepMind for non-commercial research use only. This means ProteinIQ cannot host the model on its own servers or provide a shared API key. Doing so would violate the commercial use restrictions. By using a personal API key, researchers access AlphaGenome directly through DeepMind's infrastructure under their own non-commercial research agreement. Users are responsible for ensuring their use complies with DeepMind's Terms of Use.
The API key is free for academic and non-commercial research. Organizations seeking commercial access should contact DeepMind through their dedicated inquiry form.
ProteinIQ does not store API keys in its database. Keys are stripped from job records before storage and are only used transiently to communicate with DeepMind's API. However, the key does pass through ProteinIQ's processing servers during job execution.
| Field | Description |
|---|---|
AlphaGenome API Key | Personal API key from DeepMind (required) |
Job name | Label for identifying the job in history |
| Setting | Description |
|---|---|
Chromosome | Chromosome identifier (e.g., chr1, chr22, chrX) |
Variant position | Genomic coordinate of the variant. The analysis window centers on this position. |
Reference bases | Original nucleotide(s) at the position (e.g., A, GT) |
Alternate bases | Variant nucleotide(s) to compare (e.g., C, GAA) |
Window size | Analysis region: 16K bp (fastest), , or . Larger windows capture more regulatory context but produce larger output files. |
| Setting | Description |
|---|---|
Requested outputs | Prediction type. Currently supports RNA-seq (gene expression). |
Ontology terms | Optional comma-separated UBERON (tissue) or CL (cell type) codes for tissue-specific predictions. Example: UBERON:0002107 for liver, CL:0000057 for fibroblast. |
The output includes:
.npz file containing expression predictions at every position in the window across all 667 cell types| Metric | Interpretation |
|---|---|
| Effect Mean | Average expression change across all positions and cell types |
| Effect at Variant | Predicted expression change at the exact variant position |
| Positive effect | Variant increases expression relative to reference |
| Negative effect | Variant decreases expression relative to reference |
AlphaGenome uses a hybrid architecture combining convolutional neural networks and transformers:
The model was trained on thousands of experimental datasets measuring gene expression, chromatin accessibility, histone modifications, and transcription factor binding across diverse cell types. Training completed in four hours on TPUs—half the compute of the earlier Enformer model.
For variant effect prediction, AlphaGenome runs inference twice (reference sequence and alternate sequence) and computes the difference in predicted expression values.
128K bp512K bp